Congratulations to Dr Heidi Singleton, who has received Sigma Europe’s Emerging Nurse Researcher 2023 Award.
The Sigma Emerging Nurse Researcher Award recognises early career nurse researchers whose work has significantly influenced the nursing profession. Dr Singleton won this award for her work combining evidence-based practice with innovative ideas to adapt to the changing nursing landscape.
During her PhD at BU, she researched how technology can improve student nurses’ understanding of complex concepts, such as diabetes. Her work focused on blending real-world practice methods with emerging technologies to develop nursing education in line with how the world is developing and changing.
Other research areas Dr Singleton has explored include how technology can be used therapeutically, for service improvement, mental health and anxiety – especially in children and young people. This includes the psychological impacts of eczema, innovation in nurse-led skin cancer clinics, improving early intervention services, and vaccination and hospital appointment anxiety.
Dr Singleton said: “I feel very honoured to win the Emerging Nurse Researcher Award for the Europe Region. As a new academic, I have looked up to seniors who have demonstrated excellence in their research and publications. It’s a privilege to share my research and that of my brilliant team with the world. Hopefully, this can be a good building block for my future research plans.”












BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease